Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Stock Of The Day: Moderna
Cheddar News is watching Moderna as its Stock of the Day after posting fourth-quarter results, which missed estimates.
Tips to Budget Amid High Prices
Most Americans are worried about their finances, according to a survey. Kimberly Palmer, personal finance expert at NerdWallet, joined Cheddar News to help put Americans at ease about their spending.
Load More